Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Lung Cancer

Free Subscription Articles published in Eur J Cardiothorac Surg Retrieve available abstracts of 96 articles: HTML format Text format

Single Articles

February 2020
1. JONES GD, Caso R, No JS, Tan KS, et al
   Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall.
   Eur J Cardiothorac Surg. 2020 Feb 10. pii: 5732798. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
2. REA F, Ieva F, Pastorino U, Apolone G, et al
   Number of lung resections performed and long-term mortality rates of patients after lung cancer surgery: evidence from an Italian investigation.
   Eur J Cardiothorac Surg. 2020 Feb 8. pii: 5731323. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
3. YANG MZ, Hou X, Li JB, Cai JS, et al
   Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
   Eur J Cardiothorac Surg. 2020 Feb 4. pii: 5722182. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
4. OPITZ I, Patella M, Payrard L, Perentes JY, et al
   Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis.
   Eur J Cardiothorac Surg. 2020 Feb 3. pii: 5721431. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   January 2020
5. INCI I, Benker M, Citak N, Schneiter D, et al
   Complex sleeve lobectomy has the same surgical outcome when compared with conventional lobectomy in patients with lung cancer.
   Eur J Cardiothorac Surg. 2020 Jan 9. pii: 5699252. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
6. WINCKELMANS T, Decaluwe H, De Leyn P, Van Raemdonck D, et al
   Segmentectomy or lobectomy for early-stage non-small-cell lung cancer: a systematic review and meta-analysis.
   Eur J Cardiothorac Surg. 2020 Jan 3. pii: 5695530. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   December 2019
7. BOLUKBAS S, Baldes N, Eberlein M
   Surveillance and screening in lung cancer survivors.
   Eur J Cardiothorac Surg. 2019 Dec 6. pii: 5662417. doi: 10.1093.
   PubMed     Text format    
   
   
   
8. LANUTI M
   T4 disease: exploring changes in the 8th edition of the TNM classification of lung cancer and pushing the limits.
   Eur J Cardiothorac Surg. 2019 Dec 6. pii: 5662414. doi: 10.1093.
   PubMed     Text format    
   
   
   November 2019
9. HENNON MW, DeGraaff LH, Groman A, Demmy TL, et al
   The association of nodal upstaging with surgical approach and its impact on long-term survival after resection of non-small-cell lung cancer.
   Eur J Cardiothorac Surg. 2019 Nov 25. pii: 5640487. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
10. SETOJIMA Y, Shimada Y, Tanaka T, Shigefuku S, et al
    Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.
    Eur J Cardiothorac Surg. 2019 Nov 20. pii: 5634181. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
11. TAN HX, Drake BC, Chaudhuri N, Kefaloyannis M, et al
    A risk model to predict 2-year survival after VATS lobectomy for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Nov 13. pii: 5625090. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    October 2019
12. MITCHELL J, Benamore R, Gleeson F, Belcher E, et al
    Computed tomography follow-up identifies radically treatable new primaries after resection for lung cancer.
    Eur J Cardiothorac Surg. 2019 Oct 25. pii: 5607278. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
13. YAMANASHI K, Menju T, Hamaji M, Tanaka S, et al
    Prognostic factors related to postoperative survival in the newly classified clinical T4 lung cancer.
    Eur J Cardiothorac Surg. 2019 Oct 21. pii: 5601458. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    August 2019
14. LI P, Che G
    Should there be any restriction for stage IA non-small-cell lung cancer patients to receive segmentectomy?
    Eur J Cardiothorac Surg. 2019 Aug 25. pii: 5554421. doi: 10.1093.
    PubMed     Text format    
    
    
    
15. OLLAND A, Falcoz PE
    Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Aug 1. pii: 5542615. doi: 10.1093.
    PubMed     Text format    
    
    
    July 2019
16. DENG HY, Tang X, Zhou Q
    Sublobar resection: an alternative to lobectomy in treating stage I non-small-cell lung cancer?
    Eur J Cardiothorac Surg. 2019 Jul 25. pii: 5538725. doi: 10.1093.
    PubMed     Text format    
    
    
    June 2019
17. VALO JK, Kyto V, Sipila J, Rautava P, et al
    Thoracoscopic surgery for lung cancer is associated with improved survival and shortened admission length: a nationwide propensity-matched study.
    Eur J Cardiothorac Surg. 2019 Jun 26. pii: 5523684. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
18. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Jun 23. pii: 5522159. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
19. YUN JK, Lee GD, Choi S, Kim HR, et al
    Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2019 Jun 5. pii: 5511574. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
20. STILES BM, Mao J, Harrison S, Lee B, et al
    Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Eur J Cardiothorac Surg. 2019 Jun 5. pii: 5511701. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
21. MARIJIC P, Walter J, Schneider C, Schwarzkopf L, et al
    Cost and survival of video-assisted thoracoscopic lobectomy versus open lobectomy in lung cancer patients: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2019 Jun 3. pii: 5510143. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2019
22. BENDIXEN M, Kronborg C, Jorgensen OD, Andersen C, et al
    Cost-utility analysis of minimally invasive surgery for lung cancer: a randomized controlled trial.
    Eur J Cardiothorac Surg. 2019 Mar 5. pii: 5369803. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    February 2019
23. MELEK H, Cetinkaya G, Ozer E, Yenturk E, et al
    Pathological complete response after neoadjuvant/induction treatment: where is its place in the lung cancer staging system?dagger.
    Eur J Cardiothorac Surg. 2019 Feb 26. pii: 5365486. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
24. LI H, Sun Z, Yang F, Sui X, et al
    Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study.
    Eur J Cardiothorac Surg. 2019 Feb 4. pii: 5306618. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    December 2018
25. TANAKA S, Sugimoto S, Soh J, Oto T, et al
    Long-term outcomes of pneumonectomy, back-table lung preservation, double-sleeve resection and reimplantation for advanced central lung cancer: the Oto procedure.
    Eur J Cardiothorac Surg. 2018 Dec 24. pii: 5259358. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
26. DENG HY, Zha P, Zhou Q
    Sarcopenia: an unneglectable nutritional status for patients with surgically treated non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Dec 18. pii: 5251904. doi: 10.1093.
    PubMed     Text format    
    
    
    November 2018
27. LI Q, Zhang P, Wang Y, Liu D, et al
    T4 extension alone is more predictive of better survival than a tumour size >7 cm for resected T4N0-1M0 non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Nov 30. pii: 5224799. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    October 2018
28. NGUYEN D, Gharagozloo F, Tempesta B, Meyer M, et al
    Long-term results of robotic anatomical segmentectomy for early-stage non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Oct 15. pii: 5133000. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
29. SUN C, Anraku M, Karasaki T, Kuwano H, et al
    Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Oct 4. pii: 5115406. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    September 2018
30. CHIAPPETTA M, Leuzzi G, Sperduti I, Bria E, et al
    Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis.
    Eur J Cardiothorac Surg. 2018 Sep 6. pii: 5092028. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    August 2018
31. MOKHLES S, Macbeth F, Treasure T, Younes RN, et al
    Corrigendum to 'Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small cell lung cancer: a systematic review of randomized trials and a meta-analysis' [Eur J Cardiothorac Surg 2017;51:1149-1156
    Eur J Cardiothorac Surg. 2018 Aug 16. pii: 5075054. doi: 10.1093.
    PubMed     Text format    
    
    
    
32. SUCIU BA, Halmaciu I, Vunvulea V, Brinzaniuc K, et al
    Is there any correlation between pretreatment haemoglobin levels and prognosis of patients with non-small-cell lung cancer?
    Eur J Cardiothorac Surg. 2018 Aug 8. pii: 5068216. doi: 10.1093.
    PubMed     Text format    
    
    
    July 2018
33. VARELA G, Novoa NM
    Re: Oncological results of full thoracoscopic major pulmonary resections for clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Jul 27. pii: 5060691. doi: 10.1093.
    PubMed     Text format    
    
    
    
34. LUTZ JA, Seguin-Givelet A, Grigoroiu M, Brian E, et al
    Oncological results of full thoracoscopic major pulmonary resections for clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Jul 24. pii: 5058116. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
35. SANO Y, Shigematsu H, Okazaki M, Sakao N, et al
    Hoarseness after radical surgery with systematic lymph node dissection for primary lung cancer.
    Eur J Cardiothorac Surg. 2018 Jul 13. pii: 5053975. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
36. AIGNER C
    To be or not to be central-does this really matter?
    Eur J Cardiothorac Surg. 2018;54:141.
    PubMed     Text format    
    
    
    
37. RESCIGNO G, Hogan J, Strong P
    The ideal use of dogs in medicine.
    Eur J Cardiothorac Surg. 2018;54:197.
    PubMed     Text format    
    
    
    May 2018
38. FALCOZ PE
    Re: Video-assisted thoracoscopic surgery yields better outcomes than thoracotomy for anatomical lung resection in Brazil: a propensity score-matching analysis using the Brazilian Society of Thoracic Surgery database.
    Eur J Cardiothorac Surg. 2018;53:999-1000.
    PubMed     Text format    
    
    
    April 2018
39. VERONESI G, Park B, Cerfolio R, Dylewski M, et al
    Robotic resection of Stage III lung cancer: an international retrospective study.
    Eur J Cardiothorac Surg. 2018 Apr 30. pii: 4990523. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2018
40. PAN X, Gu C, Yang J, Shi J, et al
    Robotic double-sleeve resection of lung cancer: technical aspects.
    Eur J Cardiothorac Surg. 2018 Mar 20. pii: 4944680. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
41. DZIEDZIC R, Marjanski T, Binczyk F, Polanska J, et al
    Favourable outcomes in patients with early-stage non-small-cell lung cancer operated on by video-assisted thoracoscopic surgery: a propensity score-matched analysis.
    Eur J Cardiothorac Surg. 2018 Mar 14. pii: 4934946. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
42. BATIREL HF
    Solid to ground-glass opacity ratio in lung adenocarcinomas: is it a new criterion for limited pulmonary resection?
    Eur J Cardiothorac Surg. 2018 Mar 8. pii: 4924815. doi: 10.1093.
    PubMed     Text format    
    
    
    
43. VON MEYENFELDT EM, Marres GMH, van Thiel E, Damhuis RAM, et al
    Variation in length of hospital stay after lung cancer surgery in the Netherlands.
    Eur J Cardiothorac Surg. 2018 Mar 5. pii: 4921284. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    February 2018
44. CHO S, Yum S, Kim K, Jheon S, et al
    Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Feb 27. pii: 4912385. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
45. DECALUWE H, Moons J, Fieuws S, De Wever W, et al
    Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?
    Eur J Cardiothorac Surg. 2018 Feb 13. pii: 4855994. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
46. WANG G, Ma W, Li Y, Jiang Y, et al
    Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study.
    Eur J Cardiothorac Surg. 2018 Feb 5. pii: 4838788. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
47. HONG TH, Cho JH, Shin S, Kim HK, et al
    Extended sleeve lobectomy for centrally located non-small-cell lung cancer: a 20-year single-centre experience.
    Eur J Cardiothorac Surg. 2018 Feb 2. pii: 4835395. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    January 2018
48. ARMANI G, Madeddu D, Mazzaschi G, Bocchialini G, et al
    Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Jan 15. pii: 4810371. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
49. GUNN J, Valo J, Sipila J, Rautava P, et al
    Trends and results of lung cancer surgery in Finland between 2004 and 2014.
    Eur J Cardiothorac Surg. 2018 Jan 8. pii: 4793386. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
50. XIAO F, Yu Q, Zhang Z, Liu D, et al
    Novel perspective to evaluate the safety of segmentectomy: clinical significance of lobar and segmental lymph node metastasis in cT1N0M0 lung adenocarcinoma.
    Eur J Cardiothorac Surg. 2018;53:228-234.
    PubMed     Text format     Abstract available
    
    
    December 2017
51. XIE D, Allen MS, Marks R, Jiang G, et al
    Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.
    Eur J Cardiothorac Surg. 2017 Dec 27. pii: 4780277. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
52. TAMBURINI N, Maniscalco P, Mazzara S, Maietti E, et al
    Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2017 Dec 25. pii: 4774618. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
53. WEDER W, Moghanaki D, Stiles B, Siva S, et al
    The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 21. pii: 4772266. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
54. HINO H, Karasaki T, Yoshida Y, Fukami T, et al
    Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years.
    Eur J Cardiothorac Surg. 2017 Dec 18. pii: 4759172. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
55. YENDAMURI S, Groman A, Miller A, Demmy T, et al
    Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 13. pii: 4740938. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
56. SAJI H, Ueno T, Nakamura H, Okumura N, et al
    A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303.
    Eur J Cardiothorac Surg. 2017 Dec 11. pii: 4731648. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
57. SAGAWA M, Oizumi H, Suzuki H, Uramoto H, et al
    A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity.
    Eur J Cardiothorac Surg. 2017 Dec 9. pii: 4718127. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
58. TAKIZAWA H, Kondo K, Kawakita N, Tsuboi M, et al
    Autofluorescence for the diagnosis of visceral pleural invasion in non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 8. pii: 4710341. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    November 2017
59. STILES BM, Rahouma M, Hussein MK, Nasar A, et al
    Never smokers with resected lung cancer: different demographics, similar survival.
    Eur J Cardiothorac Surg. 2017 Nov 22. pii: 4652925. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
60. SAWABATA N
    Pulmonary wedge resection for Stage I non-small-cell lung cancer: possible alternative strategy to lobectomy.
    Eur J Cardiothorac Surg. 2017 Nov 3. doi: 10.1093.
    PubMed     Text format    
    
    
    October 2017
61. DE WOLF J, Bellier J, Lepimpec-Barthes F, Tronc F, et al
    Exhaustive preoperative staging increases survival in resected adrenal oligometastatic non-small-cell lung cancer: a multicentre study.
    Eur J Cardiothorac Surg. 2017;52:698-703.
    PubMed     Text format     Abstract available
    
    
    September 2017
62. GU C, Pan X, Chen Y, Yang J, et al
    Short-term and mid-term survival in bronchial sleeve resection by robotic system versus thoracotomy for centrally located lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
63. DECALUWE H, Petersen RH, Brunelli A, Pompili C, et al
    Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
64. TSUTANI Y, Tsubokawa N, Ito M, Misumi K, et al
    Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 6. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    August 2017
65. YANG S, Guo W, Chen X, Wu H, et al
    Early outcomes of robotic versus uniportal video-assisted thoracic surgery for lung cancer: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2017 Aug 30. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
66. ABAH U, Casali G, Batchelor TJP, Internullo E, et al
    Pathological lymph node involvement is not a predictor of adverse outcomes in patients undergoing thoracoscopic lobectomy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
67. UDA K, Matsui H, Fushimi K, Yasunaga H, et al
    Preoperative short-term plus postoperative physical therapy versus postoperative physical therapy alone for patients undergoing lung cancer surgery: retrospective analysis of a nationwide inpatient database.
    Eur J Cardiothorac Surg. 2017 Aug 18. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    July 2017
68. MAO Y, Chi C, Yang F, Zhou J, et al
    The identification of sub-centimetre nodules by near-infrared fluorescence thoracoscopic systems in pulmonary resection surgeries.
    Eur J Cardiothorac Surg. 2017 Jul 27. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
69. ZEHNDER A, Kocher GJ, Seitz M, Schmid RA, et al
    IgG4-related disease of the lung: a rare differential diagnosis to lung cancer after positive positron emission tomography and biopsy.
    Eur J Cardiothorac Surg. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
70. BUGGE AS, Lund MB, Valberg M, Brustugun OT, et al
    Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
71. GUIRAO MONTES A, Molins Lopez-Rodo L, Ramon Rodriguez I, Sunyer Dequigiovanni G, et al
    Lung cancer diagnosis by trained dogs.
    Eur J Cardiothorac Surg. 2017 Jul 24. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
72. ENDO S, Ikeda N, Kondo T, Nakajima J, et al
    Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014-2015.
    Eur J Cardiothorac Surg. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
73. PERIKLEOUS P, Bilancia R, Oey I, Waller DA, et al
    Hybrid bilobectomy for treatment of an early-stage lung cancer in a patient with severe emphysema using the benefits of lung volume reduction.
    Eur J Cardiothorac Surg. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
74. YANG CC, Fong Y, Lin LC, Que J, et al
    The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
    Eur J Cardiothorac Surg. 2017 Jul 4. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    June 2017
75. CAGINI L, Balloni S, Ludovini V, Andolfi M, et al
    Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Jun 19. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    May 2017
76. SEKIHARA K, Hishida T, Yoshida J, Oki T, et al
    Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Eur J Cardiothorac Surg. 2017 May 8. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
77. NAKAJIMA J, Iida T, Okumura S, Horio H, et al
    Recent improvement of survival prognosis after pulmonary metastasectomy and advanced chemotherapy for patients with colorectal cancer.
    Eur J Cardiothorac Surg. 2017;51:869-873.
    PubMed     Text format     Abstract available
    
    
    
78. NOVOA NM, Esteban P, Rodriguez M, Gomez MT, et al
    Functional evaluation before lung resection: searching for a low technology test in a safer environment for the patient: a pilot study.
    Eur J Cardiothorac Surg. 2017;51:856-860.
    PubMed     Text format     Abstract available
    
    
    
79. CATTONI M, Vallieres E, Brown LM, Sarkeshik AA, et al
    Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours?
    Eur J Cardiothorac Surg. 2017;51:874-879.
    PubMed     Text format     Abstract available
    
    
    
80. SATO M, Kuwata T, Yamanashi K, Kitamura A, et al
    Safety and reproducibility of virtual-assisted lung mapping: a multicentre study in Japan.
    Eur J Cardiothorac Surg. 2017;51:861-868.
    PubMed     Text format     Abstract available
    
    
    April 2017
81. FILOSSO PL, Guerrera F, Evangelista A, Galassi C, et al
    Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database.
    Eur J Cardiothorac Surg. 2017 Apr 28. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
82. BENDIXEN M, Licht PB
    Video-assisted thoracoscopic surgery versus open lobectomy for lung cancer: time for a randomized trialdagger.
    Eur J Cardiothorac Surg. 2017 Apr 27. doi: 10.1093.
    PubMed     Text format    
    
    
    
83. KARENOVICS W, Licker M, Ellenberger C, Christodoulou M, et al
    Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery: a randomized controlled studydagger.
    Eur J Cardiothorac Surg. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
84. WELTER S, Arfanis E, Christoph D, Hager T, et al
    Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?dagger.
    Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
85. DZIEDZIC R, Zurek W, Marjanski T, Rudzinski P, et al
    Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registrydagger.
    Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
86. ANDERSON KL JR, Mulvihill MS, Yerokun BA, Speicher PJ, et al
    Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.
    Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2017
87. SCHIRREN J, Schirren M, Lampl L, Sponholz S, et al
    Surgery for pulmonary metastases: quo vadis?
    Eur J Cardiothorac Surg. 2017;51:408-410.
    PubMed     Text format    
    
    
    December 2016
88. GUERRERA F, Renaud S, Tabbo F, Voegeli' AC, et al
    Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomasdagger.
    Eur J Cardiothorac Surg. 2016 Dec 15. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    July 2016
89. HOFFERBERTH SC, Grinstaff MW, Colson YL
    Nanotechnology applications in thoracic surgery.
    Eur J Cardiothorac Surg. 2016;50:6-16.
    PubMed     Text format     Abstract available
    
    
    
90. DECALUWE H, Stanzi A, Dooms C, Fieuws S, et al
    Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016;50:110-7.
    PubMed     Text format     Abstract available
    
    
    
91. STAMENOVIC D, Bostanci K, Messerschmidt A, Jahn T, et al
    Fissureless fissure-last video-assisted thoracoscopic lobectomy for all lung lobes: a better alternative to decrease the incidence of prolonged air leak?
    Eur J Cardiothorac Surg. 2016;50:118-23.
    PubMed     Text format     Abstract available
    
    
    
92. CHIAPPETTA M, Nachira D, Margaritora S, Granone P, et al
    Are digital devices routinely useful in thoracic surgery or are they helpful only in selected cases?
    Eur J Cardiothorac Surg. 2016;50:192.
    PubMed     Text format    
    
    
    June 2016
93. KIRCHEVA DY, Husain AN, Watson S, Kindler HL, et al
    Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Eur J Cardiothorac Surg. 2016;49:1642-7.
    PubMed     Text format     Abstract available
    
    
    
94. WATANABE K, Tsuboi M, Sakamaki K, Nishii T, et al
    Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016;49:1624-31.
    PubMed     Text format     Abstract available
    
    
    
95. WALLER DA
    The staging of malignant pleural mesothelioma: are we any nearer to squaring the circle?
    Eur J Cardiothorac Surg. 2016;49:1648-9.
    PubMed     Text format    
    
    
    May 2016
96. SWANSON SJ
    The value of video-assisted thoracoscopic surgery: follow the money!
    Eur J Cardiothorac Surg. 2016;49:1496.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: